Stocktoria
Protara Therapeutics, Inc. TARA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2014-10-22
Protara Therapeutics, Inc. statistics & valuation
Market cap$231.6M
P / B1.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -27.4% | -24.6% | -51.2% | -58.2% | -27.4% |
| Return on equity | -29.2% | -26.7% | -59.2% | -64.6% | -29.2% |
| Current ratio | 14.58 | 15.71 | 11.17 | 15.01 | 21.66 |
Source: SEC EDGAR filings · CIK 0001359931 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.